These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6284777)

  • 1. Use of high-performance liquid chromatography-mass spectrometry for the study of the metabolism of ranitidine in man.
    Martin LE; Oxford J; Tanner RJ
    J Chromatogr; 1982 Apr; 251(2):215-24. PubMed ID: 6284777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of on-line high-performance liquid chromatography-mass spectrometry for the identification of ranitidine and its metabolites in urine.
    Martin LE; Oxford J; Tanner RJ
    Xenobiotica; 1981 Dec; 11(12):831-40. PubMed ID: 6281996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography.
    Carey PF; Martin LE; Owen PE
    J Chromatogr; 1981 Sep; 225(1):161-8. PubMed ID: 6271798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and quantitative analysis of ranitidine and its metabolites by high-performance liquid chromatography-mass spectrometry.
    Lant MS; Martin LE; Oxford J
    J Chromatogr; 1985 Apr; 323(1):143-52. PubMed ID: 4008551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-pressure liquid chromatographic determination of ranitidine, a new H2-receptor antagonist, in plasma and urine.
    Mihaly GW; Drummer OH; Marshall A; Smallwood RA; Louis WJ
    J Pharm Sci; 1980 Oct; 69(10):1155-7. PubMed ID: 6252316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of ranitidine and its metabolites in human plasma and urine by high-performance liquid chromatography.
    Prueksaritanont T; Sittichai N; Prueksaritanont S; Vongsaroj R
    J Chromatogr; 1989 May; 490(1):175-85. PubMed ID: 2760148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine bioavailability and kinetics in normal male subjects.
    Garg DC; Weidler DJ; Eshelman FN
    Clin Pharmacol Ther; 1983 Apr; 33(4):445-52. PubMed ID: 6299642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for the determination of ranitidine and its metabolites in urine by h.p.l.c. and its application to study the metabolism and pharmacokinetics of ranitidine in man.
    Carey PF; Martin LE; Owen P
    Biochem Soc Trans; 1981 Feb; 9(1):112. PubMed ID: 6111505
    [No Abstract]   [Full Text] [Related]  

  • 9. Ranitidine kinetics in normal subjects.
    Chau NP; Zech PY; Pozet N; Hadj-Aissa A
    Clin Pharmacol Ther; 1982 Jun; 31(6):770-4. PubMed ID: 6280919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic analysis of ranitidine in plasma and urine.
    Shiekh Salem M; Gharaibeh AM; Alkaysi HN; Badwan A
    J Clin Pharm Ther; 1988 Oct; 13(5):351-7. PubMed ID: 3230100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ranitidine in serum by high performance liquid chromatography.
    Vandenberghe HM; MacLeod SM; Mahon WA; Lebert PA; Soldin SJ
    Ther Drug Monit; 1980; 2(4):379-84. PubMed ID: 6111854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved high-performance liquid chromatographic assay for cimetidine using ranitidine as an internal standard.
    Fleitman J; Torosian G; Perrin JH
    J Chromatogr; 1982 Apr; 229(1):255-8. PubMed ID: 6282913
    [No Abstract]   [Full Text] [Related]  

  • 15. A sensitive and rapid determination of ranitidine in human plasma by HPLC with fluorescence detection and its application for a pharmacokinetic study.
    Ulu ST; Tuncel M
    J Chromatogr Sci; 2012 Apr; 50(4):301-6. PubMed ID: 22345389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid analysis of ranitidine in biological fluids and determination of its erythrocyte partitioning.
    Mullersman G; Derendorf H
    J Chromatogr; 1986 Sep; 381(2):385-91. PubMed ID: 3760093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine.
    Young CJ; Daneshmend TK; Roberts CJ
    Gut; 1982 Oct; 23(10):819-23. PubMed ID: 6126422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive determination of ranitidine in rabbit plasma by HPLC with fluorescence detection.
    Khedr A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 862(1-2):175-80. PubMed ID: 18166505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated solid-phase extraction and high-performance liquid chromatographic determination of ranitidine from urine, plasma and peritoneal dialysate.
    Karnes HT; Opong-Mensah K; Farthing D; Beightol LA
    J Chromatogr; 1987 Nov; 422():165-73. PubMed ID: 3437005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel gradient HPLC method for simultaneous determination of ranitidine, methylparaben and propylparaben in oral liquid pharmaceutical formulation.
    Kokoletsi MX; Kafkala S; Tsiaganis M
    J Pharm Biomed Anal; 2005 Jul; 38(4):763-7. PubMed ID: 15967306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.